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Abstract 
MAP kinases of ERK family play important roles in oocyte maturation, fertilization, 
and early embryo development. The role of the signaling pathway involving ERK5 
MAP kinase during meiotic and mitotic M-phase of the cell cycle is not well known. 
Here we studied localization of phosphorylated, thus, activated form of ERK5 in 
mouse maturing oocytes and mitotically dividing early embryos. We show that 
phosphorylation/dephosphorylation, i.e. activation/inactivation of ERK5 correlates 
with M-phase progression. Phosphorylated form of ERK5 accumulates in division 
spindle of both meiotic and mitotic cells, and precisely co-localizes with spindle 
microtubules at metaphase. This localization changes drastically in anaphase when 
phospho-ERK5 completely disappears from microtubules and transits to the 
cytoplasmic granular, vesicle-like structures. In telophase oocytes it becomes 
incorporated into the midbody. Localization of phospho-ERK5 suggests that it may 
play important role both in meiotic and mitotic division. 
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Introduction 
 MAPK (Mitogen Activated Protein Kinase) signaling pathways are implicated in 
the regulation of wide range of cellular processes such as proliferation, differentiation, 
and apoptosis [1]. Their function has been analyzed in various somatic cells [2-6], as 
well as in oocytes and embryos (e.g. [7, 8]). BMK1/ERK5/MAPK7 (Mitogen-activated 
protein Kinase 1/Extracellular signal-Regulated Kinase 5/Mitogen Activated Protein 
Kinase 7; further called by us ERK5) is one of the less characterized MAP kinases of 
the ERK family. ERK5 mouse knock-out mice proved that the major developmental 
function of this kinase is related to the placental, cephalic, hindgut, and, importantly, 
cardiovascular development [9-13]. Thus, mouse embryos lacking functional ERK5 
gene failed to progress beyond E10.5, but until this developmental stage the cellular 
proliferation seemed unperturbed. Further analyses suggested, however, that ERK5 
is activated at G2-M transition, and thus, involved in the regulation mitotic division [2, 
14-16]. Details of the mitotic function of this kinase have been analyzed in somatic 
cells, but have never been previously reported in oocytes or in embryonic cells. 
 Among the MAP kinases family members studied so far in oocytes and 
embryos, the function of only ERK1 and ERK2 is the best known. These two MAP 
kinases are activated by Mos-MEK1 pathway and are necessary for the 
establishment of CSF (cytostatic factor) mediated arrest of metaphase II oocytes in 
mouse [8, 17] as well as in frog [18]. Special attention was paid to ERK1 and ERK2 
MAPK pathway since it was shown to be necessary to sustain the meiotic arrest of 
maturing vertebrate oocytes, establishment of oocyte polarity and impacting at the 
correct size of the polar body (e.g. [19-24]). In-gel MBP kinase assay performed 
using mouse oocytes and one-cell embryos proved that ERK1 and ERK2 activity is 
high exclusively in oocytes,  but undetectable during mitotic divisions of early mouse 
embryos [8, 25]. The same assay showed also that other MBP (myelin basic protein, 
i.e. MAPK substrate) phosphorylating kinases are active both in oocytes and 
mitotically dividing embryos [8, 26], suggesting potential role of other MAP kinases in 
regulation of early embryonic mitosis. ERK5 is likely to fulfill this role. The evidence 
supporting the idea of ERK5 involvement both in meiosis and mitosis comes from 
analyses of MAP kinases substrates. Phosphorylated form of one of them, i.e. 
p90Rsk1, was detectable in meiotically dividing mouse oocytes, when ERK1 and ERK2 
are fully activated, but also during the first mitosis of mouse embryo, when the two 
ERK kinases remain inactive [[25], our unpublished data]. Since p90rsk1 was shown to 
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be phosphorylated by ERK5 in somatic cells [3], it is likely that p90rsk1 is activated by 
the same pathway during M-phase of oocytes and early embryos. ERK5-encoding 
mRNA was detected in unfertilized oocytes, and in preimplantation embryos up to 
blastocyst stage suggesting that the protein could be present at that stages [7].The 
presence of ERK5 protein in oocytes was shown using Western blotting analysis of 
pig oocytes lacking precise localization analysis [27]. Similarly, Wang et al. presented 
Western blot analysis of preimplantation mouse embryos (3.5 days of development) 
and non-conclusive immunodetection of active and inactive forms of this antigens [7]. 
 In the current paper we show that ERK5 is present in mouse oocytes and early 
embryo and that its activation is precisely regulated during each of M-phases studied 
and that its association with both meiotic and mitotic spindle is highly controlled 
during M-phase progression.  
 
Material and Methods 
Ethical issues 
 All animal studies presented were approved by Local Ethic Committee No. 1 in 
Warsaw, Poland according to European Union Council Directive 86/609/EEC of 24 
November 1986. All animals were raised on the premises.  
 
Collection and culture of oocytes at germinal vesicle stage 
 Two- to three-month-old F1 (C57Bl/10 x CBA/H) female mice were injected 
intraperitoneally with 10 IU pregnant mare serum gonadotrophin (PMSG; Folligon, 
Intervet, Netherlands) to stimulate the development of ovarian follicles. Forty-eight to 
fifty-two hours later females were killed by cervical dislocation. Fully grown oocytes 
arrested at prophase of the first meiotic division [germinal vesicle stage (GV)] were 
released from ovarian follicles. Oocytes were freed from cumulus cells by pipetting 
and then cultured for 2 h in M2 medium [medium M16 buffered with HEPES; [28]] 
containing bovine serum albumin (BSA; 4 mg/ml). Oocytes were fixed subjected to 
immunofluorescence at GV stage, at the GVBD (germinal vesicle breakdown) and at 
selected, subsequent stages of in vitro maturation.  
 
Collection, parthenogenetic activation of ovulated oocytes and in vitro culture of one- 
and two-cell embryos, blastocysts.  
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 F1 females were superovulated by injection of 10 IU of eCG and 10 IU of hCG 
(Intervet, Netherlands) 48-52 hours apart. Ovulated oocytes were collected 17-18 
hours after hCG injection and cumulus cells were removed with hyaluronidase 
(Sigma Aldrich, Germany, 300 units/ml PBS). For the parthenogenetic activation the 
oocytes were exposed to 8% ethanol (POCh, Poland) in M2 medium for 8 minutes at 
room temperature [29], washed carefully and cultured in M2. Only those oocytes that 
extruded polar bodies and formed pronuclei were used for further analyses. Starting 
at 14 hours after activation embryos were scored every 10 minutes to determine the 
timing of the nuclear envelope breakdown (NEBD) and then collected for further 
analyses at different time after NEBD. Fertilized two-cell embryos were obtained from 
superovulated and mated females 49 hours after hCG. Embryos were collected and 
cultured in M2 medium. Starting from 49 hours after hCG embryos were observed 
every 10 minutes to determine the timing of NEBD and collected for further analyses 
at different times after NEBD. Blastocysts were obtained from uteri of superovulated 
and mated females at 90 hours after hCG. 
 
In vitro culture of murine NIH3T3 fibroblasts and C2C12 myoblasts. 
 NIH3T3 fibroblasts were cultured in Dulbecco's modified Eagle's medium 
supplemented (DMEM, Invitrogen) with 10 % fetal calf serum (FCS) and antibiotics 
(Invitrogen) at 37°C in 5 % CO2. Media were supplemented with penicillin (100 
Units/ml) and streptomycin (100 mg/ml). Cells were fixed 48 hrs after plating and 
processed for Western blotting and immunodetection of tubulin and phospho-ERK5 
epitopes. C2C12 murine myoblasts cell line was obtained from the European 
Collection of Cell Cultures (ECACC no. 91031101, passage no. 13). Cells were 
cultured in high-glucose DMEM supplemented with 10% FCS and antibiotics at 37°C 
in 5 % CO2. Cells were fixed and processed for immunodetection of tubulin and 
phospho-ERK5 epitopes at day 2 after plating, i.e. at the proliferative stage.  
 
Western blotting 
 Protein samples of NIH3T3 cells were subjected to electrophoresis on 9 % 
SDS-PAGE gels [30]. Separated proteins were transferred to nitrocellulose 
membranes (Hybond C, Amersham Biosciences) and probed with rabbit polyclonal 
primary antibodies either against ERK5 or Phospho-ERK5 (Upstate) at the dilution of 
1:1000. Next, α-tubulin was immunodetected with mouse monoclonal antibody 
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(Sigma Aldrich, Germany). Antigen–antibody complexes were revealed using alkaline 
phosphatase conjugated anti-rabbit or anti-mouse secondary antibody (diluted 
1:20,000, Jackson ImmunoResearch, USA) in combination with Enhanced 
Chemifluorescence reagent (ECF; Amersham Biosciences). Signal quantification was 
performed using ImageQuant 5.2 software (Amersham Biosciences). 
 
Immunofluorescence 
 NIH3T3 cells and C2C12 myoblasts plated and cultured on glass coverslips 
were fixed in 3.7 % paraformaldehyde in PBS for 10 min at room temperature and 
permeabilized with 0.1% Triton X100 in PBS for 5 min. Oocytes, embryos were fixed 
in 3.7 % paraformaldehyde in PBS for 30 min at room temperature and permeabilized 
with 0.1% Triton X100 in PBS for 5 min. Non-specific binding was blocked by 1 h long 
treatment with 3% BSA in PBS. Rabbit polyclonal antibodies against phospho-ERK5 
(Upstate Biotechnology, USA) were used at the dilution of 1:200 and the incubation 
was performed overnight at 4°C. Next, α-tubulin was immunodetected with mouse 
monoclonal antibody (Sigma Aldrich, Germany) followed by FITC-labeled anti-rabbit 
and TRITC-labeled anti-mouse antibodies (Jackson ImmunoResearch, USA). 
Chromatin was visualized either with chromomycin A3 (Sigma Aldrich, Germany) 
diluted 1:1000 in PBS with 5 mM MgCl2 for 0.5 h at room temperature or propidium 
iodide present in mounting medium (Vector Laboratories, USA). Samples incubated 
in chromomycin A3 were mounted in Citifluor (Citifluor Ltd, Great Britain) on glass 
slides. Immunofluorescence analysis was accompanied by appropriate negative 
controls, i.e. samples that were not subjected to the primary antibodies, but instead 
they were incubated in 3% BSA in PBS. All samples were examined with laser 
scanning confocal microscope (Axiovert 100M, Carl Zeiss Jena, Germany) and 
processed with Adobe Photoshop 6.0. 
 
Results & Discussion 
 Since ERK5 is known to be phosphorylated upon M-phase in human cells [2, 
16, 31], and its role in mammalian meiosis is virtually unknown, we decided to begin 
characterization of this MAP kinase in mouse oocytes by follow the dynamics in its 
phosphorylation state using a specific anti-phospho-ERK5 (P-ERK5) antibody. 
In germinal vesicle (GV) stage oocytes (meiotic prophase I) phosphorylated 
ERK5 is absent from the GV and is detected as a background staining within the 
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cytoplasm (Fig. 1, GV). Following M-phase entry, upon germinal vesicle breakdown 
(GVBD), the P-ERK5 signal becomes detectable close to condensing bivalents (Fig. 
1, GVBD + 1h). This staining increases with the progression of the prometaphase 
and reflects organization of microtubules forming meiotic spindle around the 
individualized bivalents. The intensity of the staining is the highest in the vicinity of 
the chromosome bivalents (Fig. 1, GVBD+3h). In metaphase of the first meiotic 
division P-ERK5 localizes entirely to the spindle microtubules and the background, 
i.e. cytoplasmic staining, becomes negligible (Fig. 1, metaphase I). At the time of the 
first polar body extrusion, at the anaphase I/telophase I transition, P-ERK5 is no more 
detectable on the spindle microtubules, however, remains clearly positioned next to 
telophase groups of chromatin and within the midbody, concomitantly with the 
decrease in the cytoplasmic staining (Fig. 1, telophase I). During the metaphase of 
the second meiotic division P-ERK5 staining becomes again localized exclusively to 
the meiotic spindle, as during the metaphase I (Fig. 1, metaphase II).  At this stage 
the cytoplasmic staining is also reduced to the minimum. Thus, the P-ERK5 
localization in oocytes undergoing meiotic maturation shows that active form of ERK5 
MAP kinase localizes specifically to the meiotic spindle. The affinity of ERK5 to the 
spindle microtubules manifests very early upon GVBD and progresses during the 
long, taking about 8 hours, metaphase I. The progressive incorporation of ERK5 to 
the spindle is manifested by its total disappearance from the cytoplasm when the 
meiotic spindle is fully assembled both in metaphase I and II. Microtubule-associated 
localization of other MAP kinases, and some of their activators was reported before.  
ERK1/ERK2 activating MEK1/2 kinase was shown to be limited to the meiotic 
spindle, and its active form was shown to be located within the midbody during 
anaphase [32, 33]. In contrary ERK1/2 MAP kinases were detectable at the spindle 
poles  [8]. ERK3  was also recently reported to co-localize to spindle microtubules, 
however, the activation of this kinase was not investigated [34]. The localization and 
activation of ERK5 in mouse oocytes and early embryos was not precisely studied so 
far, however, its expression was shown in pig oocytes [27], and mouse 
preimplantation embryos [7]. However, images of ERK5 and P-ERK5 localization in 
mouse blastocysts, presented by Wang and colleagues showed high, and uniform 
signal within the cytoplasm of inner cell mass and trophectoderm cells [7], clearly 
different that in oocytes studied by us. This prompted us to analyze the P-ERK5 
localization also in preimplantation mouse embryos. 
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 To verify the specificity of the antibody used we performed Western blotting 
and immunolocalization analyses of total ERK5 and P-ERK5 in murine somatic 
NIH3T3 cells. Similarly as presented by others (e.g. [2, 16]) we detected a clear 
increase in phosphorylated, up-shifted form of ERK5 in nocodazole-synchronized, i.e. 
mitotic cells. These result was obtained using both anti-total ERK5 (Fig. 2A, ERK5) 
and anti-P-ERK5 antibody (Fig. 2B, P-ERK5). Importantly, the phosphorylated form of 
ERK5  localized not only to the meiotic spindles, as described above, but also to the 
mitotic spindle, as shown for mouse NIH3T3 cells (Fig. 2B) and in murine C2C12 
myoblasts (Fig. 2C). In the interphase NIH3T3 and C2C12 cells a low cytoplasmic 
staining is detectable, while the nuclei are entirely devoid of P-ERK5 (Fig. 2B and 2C, 
white asterisks). The nuclear localization of P-ERK5 becomes clear during prophase 
(Fig. 2B and C, prophase). Further, in M-phase, the P-ERK5 staining is restricted to 
the mitotic spindle only in NIH3T3 cells (Fig. 2B, M-phase), while in murine myoblasts 
C2C12 P-ERK5 colocalizes not only to the spindle, but also to chromosomes (Fig. 
2C, M-phase). Thus, Western blotting and also immunolocalization confirm that the 
signal detected in murine oocytes corresponds to the phosphorylated form of ERK5. 
 To perform precise analysis of P-ERK5 during M-phase progression in 
embryonic cells, we studied the well characterized model of mitotically dividing 
mouse one-cell embryos. The first mitotic division of mouse embryo can serve, due to 
its length of approximately 120 minutes, as a useful tool to study the mitotic events 
[35-39].  This feature allowed us to precisely analyze the localization, and dynamics 
of ERK5 activation in M-phase. At metaphase of the first mitotic division of one-cell 
embryos, similarly as it was shown for oocytes, P-ERK5 perfectly colocalized to the 
spindle microtubules (Fig. 3A, metaphase). Moreover, the cytoplasmic staining was 
not detected. As soon as the anaphase started the pattern of P-ERK5 localization 
changed dramatically. First of all the P-ERK5 signal was lost from the microtubules, 
and becomes visible as diffused cloud around the spindle (Fig. 3A, early anaphase). 
This signal dispersed during the progresses to late anaphase and beginning of 
cytokinesis (Fig. 3A, late anaphase). Concomitantly, the cytoplasmic staining 
increased (Fig. 3A, early and late anaphase). Thus, following the metaphase-
anaphase transition P-ERK5 is no longer present on spindle microtubules, but seems 
to disperse around the anaphase spindle and further within the cytoplasm. Similar 
localization of P-ERK5 within the mitotic spindle was observed in two cell stage 
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blastomeres (Fig. 3B), and at further stages of preimplantation development (Fig. 
3C).  
 These results show that: 1) ERK5 is phosphorylated upon M-phase entry in 
meiosis and mitosis; 2) in both cases it localizes to the metaphase spindle 
microtubules; 3) and disappears from the spindle in early anaphase. Such 
localization suggests that ERK5 plays a similar function in spindle assembly/function 
in oocytes, embryos and somatic cells.  
ERK5/ BMK1/MAPK7 belongs to the subfamily of the MAP kinase family in 
mammals, and it has some characteristic features: a large C-terminus and a unique 
loop 12 sequence [40]. Mammalian ERK5 was shown to be activated by oxidative 
stress, hyperosmolarity and several growth factors, including epidermal growth factor 
and nerve growth factor [40-45]. The mitotic function of ERK5 was suggested by the 
results of the experiments focusing at both non-transformed cells such as fibroblasts 
and transformed cell lines such as HeLa cells. In HeLa cells expressing of 
constitutively active MEK5, and as a result activation of ERK5, leads to the increase 
in the number of mitotic cells [2]. On the other hand the use of the dominant negative 
form of ERK5, or siRNA suppressing ERK5 expression reduced mitotic index of 
analyzed cells [2]. Moreover, siRNA depletion of ERK5 decreases cell survival of 
mitotically dividing cells [14]. However, the fact that mouse embryos lacking 
functional ERK5 gene are able to survive until approximately E10.5 strongly suggests 
that ERK5 function can be replaced by another enzyme. Other MAP kinases, like 
ERK1 and ERK2, are candidates for such function. Despite that localization of ERK1 
and ERK2 does not precisely reflect the P-ERK5 position within the mitotic spindle, it 
is well known that these kinases play a crucial function in meiotic spindle organization 
and function [8].  Analyses of oocytes of Mos kinase, an upstream ERK1/2 activating 
kinase, deficient mice, proved that ERK1/2 regulate microtubule dynamics [17, 19, 
20]. Recent discoveries of ERK3 localization and function in mouse oocytes identify a 
new candidate, which together with ERK1/2 and ERK5, might be involved in the 
regulation of spindle dynamics [34]. ERK3 was shown to be crucial for the successful 
mouse development, but again, similarly as it was described for ERK5 knock-out 
mice, ERK3 deficiency did not prohibit mitotic divisions of vast majority of embryonic 
tissues [46]. This kinase, however, similarly do ERK1/2 and ERK5, was shown to be 
phosphorylated during M-phase entry and dephosphorylated at metaphase/anaphase 
transition [47]. The ERK4-deficient mice also did not reveal any significant mitotic 
 10 
phenotype, moreover, these animals were not only viable but also fertile [48]. Thus, 
only the perturbation of the activity ERK1/2 MAP kinases pathway, as shown by Mos 
knock-out mice analyses, has fatal consequences for the mouse fertility impacting at 
the oocyte maturation [49, 50]. Mos knockout does not influence the mouse embryo 
development and animal viability probably due to ERK1 and ERK2 activation via 
Ras/Raf pathway [51]. However, it is possible that other MAPK, such as ERK5, may 
also act to rescue Mos deficiency following fertilization. Further studies will be 
necessary to solve this issue. 
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Legend to Figures 
 
Fig. 1. 
P-ERK5 localization in maturing mouse oocytes. Oocytes were analyzed at GV 
stage, and than during the formation of the metaphase plate and spindle of the first 
meiotic division (1 and 3 h after GVBD), at metaphase I (5 h after GVBD), telophase I 
(8 h after GVBD) and at metaphase II (9 h after GVBD). Top row - 
immunolocalization of P-ERK (green) and chromatin visualization (blue), overlay; 
bottom row - immunolocalization of P-ERK (green). 
 
Fig. 2. 
P-ERK5 in murine NIH3T3 fibroblasts and C2C12 myoblasts. A. Immunoblotting 
of ERK5 and P-ERK5 in lysates of asynchronously growing and nocodazole 
synchronized NIH3T3 fibroblasts. Note the presence of upper, slow-migrating, i.e. 
phosphorylated form of ERK5 in nocodazole treated cells. Immunodetection of α-
tubulin was performed to show the equal loading of the analyzed samples; B. 
Immunolocalization of P-ERK5 in asynchronously growing NIH3T3 fibroblasts’ C. 
Immunolocalization of P-ERK5 in asynchronously growing C2C12 myoblasts. NIH3T3 
and C2C12 cells were fixed in interphase, prophase and metaphase. Top row – 
immunolocalization of P-ERK5 (green), α-tubulin (red), and visualization of chromatin 
(blue), overlay; middle row - immunolocalization of α-tubulin (red); bottom row - 
immunolocalization of P-ERK5 (green). Note the P-ERK accumulation in prophase 
nuclei and spindle and chromosome localization in metaphase. White stars indicate 
interphase nuclei lacking P-ERK5 staining.  
 
Fig. 3 
P-ERK5 localization in preimplantation mouse embryos. A. One-cell mouse 
parthenogenetic embryos fixed at metaphase and anaphase of first mitotic division. 
B. Two-cell mouse embryo fixed at metaphase of the second mitotic division. C. 
Mitotically dividing inner cell mass in blastocyst. Top row – immunolocalization of P-
ERK5 (green), α-tubulin (red), and visualization of chromatin (blue), overlay; middle 
row - immunolocalization of α-tubulin (red); bottom row - immunolocalization of P-
ERK5 (green). 
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